Evidence map›Paper›PMID 12060742›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Regulatory interaction of phosducin-like protein with the cytosolic chaperonin complex.

Joseph N McLaughlin, Craig D Thulin, Sarah J Hart, Katheryn A Resing, Natalie G Ahn, Barry M Willardson

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Mechanism and Function of Group II Chaperonins.Journal of molecular biology · 2015
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Phosducin-like protein 1 is essential for G-protein assembly and signaling in retinal rod photoreceptors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  17. Folding of large multidomain proteins by partial encapsulation in the chaperonin TRiC/CCT.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joseph N McLaughlinDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Craig D Thulin
Sarah J Hart
Katheryn A Resing
Natalie G Ahn
Barry M Willardson
Howard Hughes Medical Institute · USUniversity of Colorado Boulder · US

Funding

Structural basis for chaperone-dependent folding of beta-propeller proteins essential for visionR01EY012287 · NEI · BRIGHAM YOUNG UNIVERSITY · PI WILLARDSON, BARRY M · 1999 to 2022
$5.7M
6 · The paper itself

Abstract

Phosducin and phosducin-like protein (PhLP) bind G protein betagamma subunits and regulate their activity. This report describes a previously uncharacterized binding partner unique to PhLP that was discovered by coimmunoprecipitation coupled with mass spectrometric identification. Chaperonin containing tailless complex polypeptide 1 (CCT), a cytosolic chaperone responsible for the folding of many cellular proteins, binds PhLP with a stoichiometry of one PhLP per CCT complex. Unlike protein-folding substrates of CCT, which interact only in their nonnative conformations, PhLP binds in its native state. Native PhLP competes directly for binding of protein substrates of CCT and thereby inhibits CCT activity. Overexpression of PhLP inhibited the ability of CCT to fold newly synthesized beta-actin by 80%. These results suggest that the interaction between PhLP and CCT may be a means to regulate CCT-dependent protein folding or alternatively, to control the availability of PhLP to modulate G protein signaling.

Indexed as

ActinsAnimalsBinding, CompetitiveCarrier ProteinsChaperoninsCHO CellsCloning, MolecularCricetinaeCytosolDNA, ComplementaryEscherichia coliKineticsMass SpectrometryMolecular ChaperonesNerve Tissue ProteinsProtein FoldingActinsCarrier ProteinsChaperoninsDNA, ComplementaryMolecular ChaperonesNerve Tissue ProteinsPdcl protein, ratRecombinant Proteins

Identifiers

PMID12060742
PMCPMC123003
OpenAlexW2097241308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.